Hegseth's new testosterone standard for troops could undercut military's transgender ban, judge says

A federal judge has raised concerns that Defense Secretary Pete Hegseth’s new policy requiring troops to meet specific testosterone levels could undermine the military’s existing transgender service member restrictions. The ruling came in a case challenging the administration’s stance on allowing transgender individuals to serve openly. Judge Ana Reyes, a Biden appointee, issued the order on Wednesday, directing the Department of Defense to clarify its reasoning regarding the new policy and how it differs from the broader military health standards outlined in the "Military Ban." The judge took judicial notice of the new testosterone standard, meaning she will consider it as part of her evaluation of the legal challenges surrounding the transgender service policy. In her order, she emphasized the need to examine how the new policy might affect the legal arguments presented by both sides. She requested that the government provide detailed explanations on why the new approach treats transgender service members differently than the general population, particularly concerning the administration of testosterone treatments. According to the court documents, the new policy requires all troops aged 30 and older to undergo automatic screening for testosterone deficiency, while younger service members may choose to volunteer for testing. If deficiencies are found, they would be eligible for testosterone replacement therapy, though the treatment would be optional. This marks a shift from previous policies that focused more broadly on gender identity and health standards. Defense Secretary Hegseth explained the policy during a recent video address, stating that the initiative aims to restore and optimize soldiers' natural capabilities. He emphasized that the program is not about enhancing performance artificially but rather about maintaining biological readiness and ensuring long-term health and combat effectiveness. His comments underscored the administration’s focus on aligning military health protocols with scientific understanding of hormonal balance. The Pentagon has not yet commented publicly on the judge’s order, as the case remains active and under review. Legal experts suggest that the judge’s decision highlights growing tensions over how the military balances health regulations with inclusivity policies. The new testosterone standard introduces a potential loophole that could challenge the current framework of the transgender service policy, prompting further scrutiny of the administration’s approach. Legal filings indicate that the judge is seeking clarity on whether the new policy creates disparities in how different groups of service members are treated medically. Specifically, she wants to know if the administration views transgender individuals as needing special provisions that differ from those available to non-transgender personnel. This question is central to the ongoing litigation, which seeks to determine the legality of the military’s stance on transgender service members. As the case moves forward, the outcome could influence future military health policies and the rights of transgender individuals within the armed forces. The judge’s order signals that the court is actively engaged in evaluating the implications of the new testosterone standard, potentially setting a precedent for how such policies are interpreted and enforced. The next steps involve the submission of additional legal briefs from both the defense and the plaintiffs, which will likely shape the trajectory of the case and its eventual resolution.